{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:42:42Z","timestamp":1790419362366,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jacc.2017.11.020","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T11:08:30Z","timestamp":1516100910000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left\u00a0Bundle Branch Block"],"prefix":"10.1016","volume":"71","author":[{"given":"Edward","family":"Sze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen Bova","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak","family":"Loring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Atwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chiswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Kisslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Daubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.11.020_bib1","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"Nishimura","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2017.11.020_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jacc.2008.10.005","volume":"53","author":"Patel","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib5","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib6","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacc.2012.07.009","article-title":"2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"60","author":"Tracy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","article-title":"Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)","volume":"123","author":"Zareba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCULATIONAHA.109.894774","article-title":"Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric\u00a0remodeling during cardiac resynchronization therapy","volume":"121","author":"Sweeney","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.110.956011","article-title":"Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients","volume":"122","author":"Bilchick","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib12","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacc.2012.10.053","article-title":"Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy","volume":"61","author":"Vaillant","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurheartj\/ehi008","article-title":"Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion","volume":"26","author":"Vernooy","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib15","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/eurheartj\/ehi580","article-title":"Bundle-branch block in middle-aged men: risk of complications and death over 28 years. The Primary Prevention Study in Goteborg, Sweden","volume":"26","author":"Eriksson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.amjcard.2006.03.044","article-title":"Prognostic significance of incident complete left bundle branch block observed over a 40-year period","volume":"98","author":"Imanishi","year":"2006","journal-title":"The Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib17","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.amjcard.2017.08.003","article-title":"Comparison of incidence of left ventricular systolic dysfunction among patients with left bundle branch block versus those with normal QRS duration","volume":"120","author":"Sze","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(05)74356-7","article-title":"The Cardiac Insufficiency Bisoprolol Study II","volume":"353","author":"Drummond","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.020_bib19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib21","first-page":"V30","article-title":"The mortality effect of metoprolol CR\/XL in patients with heart failure: results of the MERIT-HF Trial","volume":"22 Suppl 5","author":"Goldstein","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.020_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1388-9842(03)00112-0","article-title":"VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context","volume":"5","author":"Velazquez","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.020_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.020_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ahj.2015.08.004","article-title":"The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison","volume":"170","author":"Velazquez","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.amjcard.2010.11.010","article-title":"Defining left bundle branch block in the era of cardiac resynchronization therapy","volume":"107","author":"Strauss","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2307\/3001913","article-title":"Comparing individual means in the analysis of variance","volume":"5","author":"Tukey","year":"1949","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2017.11.020_bib30","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.020_bib32","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.96.7.2197","article-title":"Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS)","volume":"96","author":"Lechat","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.020_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy","volume":"109","author":"Doughty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.CIR.88.2.481","article-title":"Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators","volume":"88","author":"Pouleur","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib37","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","article-title":"Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction","volume":"111","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.020_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2015.06.020","article-title":"Identification of typical left bundle branch block contraction by strain echocardiography is additive to electrocardiography in prediction of long-term outcome after cardiac resynchronization therapy","volume":"66","author":"Risum","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.020_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2013.01.011","article-title":"The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development","volume":"165","author":"Nada","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib40","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/eurheartj\/ehq407","article-title":"Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT","volume":"32","author":"Barsheshet","year":"2011","journal-title":"Eur Hear J"},{"key":"10.1016\/j.jacc.2017.11.020_bib41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ejhf.795","article-title":"Predictors of short-term clinical response to cardiac resynchronization therapy","volume":"19","author":"Linde","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.020_bib42","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.020_bib43","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.echo.2016.08.006","article-title":"Critical review of current approaches for echocardiographic reproducibility and reliability assessment in clinical research","volume":"29","author":"Crowley","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2017.11.020_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehs305","article-title":"Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction","volume":"34","author":"Lund","year":"2013","journal-title":"Eur Heart J"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2018.02.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717416342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717416342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:49:11Z","timestamp":1656730151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717416342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0735109717416342"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.020","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left\u00a0Bundle Branch Block","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}